i
This article was retracted on
Since the first paper was published using the word probiotics by Lilly and Stillwell [1] more than 54.000 papers have been published according to Web of Science. Probiotics are live organisms present in food [2,3], human and animal gastrointestinal (GI) tract [4,5]. The International Scientific Association of Probiotics and Prebiotics recommendations for the scope probiotics, see Table 1. The probiotic microorganisms or friendly microbes, and they provide numerous health-beneficial effects to the host such as inhibition of adherence and colonization of pathogens, enhanced immune system, reduction of toxins, reduction of inflammatory bowel diseases, reduce cholesterol levels, prevention of cancer, synthesis of vitamins, and production of antimicrobial compounds [5–8]. Consumer awareness is the main reason for the development of probiotic functional food products. In this regard, probiotics incorporated in food products significantly enhanced the quality, taste, and flavour compared to non-probiotic functional foods. Furthermore, probiotic food products protect against unfavourable conditions and increased shelf-life periods [9,10]. Probiotics with their consolidated history represent an excellent resource of natural products used as an alternative therapy, representing an essential component of traditional medicines. Therefore, the use of probiotics can be a promising alternative for the control of infectious diseases [11,12]. Probiotics with conventional antimicrobial activity offers another field of application and can be widely pursued as a therapeutic approach capable of sensitizing resistant pathogens and contributing to limiting the host’s biology, and can disrupt GI integrity, alter the microbiota composition, and provoke oxidative and inflammatory responses. For example, a Chinese study evaluated the effect of microplastics and disturbance of the gut microbiota in preschool children in Xiamen [24]. Probiotics, known for their gut health benefits, are being explored for their ability to mitigate these effects. In the review paper of Demarquoy [25] the author discussed evidence from in vitroand in vivostudies on how MPs impact the probiotic viability, adhesion, and biofilm formation, and how certain strains may counter MP- induced toxicity by modulating oxidative stress, immune function, and the epithelial barrier integrity. Regarding the concerns that MPs in the GI tract may hamper the colonization efficiency and persistence of probiotics, thus potentially diminishing their therapeutic efficacy, while in vitro experiments have demonstrated that Lactiplantibacillus plantarum and Bacillus subtilis creased biofilm formation when exposed to MPs. Furthermore, the manuscript discusses emerging applications in environmental microbiology, such as the potential use of native and engineered probiotics for microplastic bioremediation. Although current data highlight promising avenues, key gaps remain in our understanding of strain-specific mechanisms, long-term efficacy, and real-world applicability. By addressing these key gaps will be essential to advance probiotic-based strategies in human contexts and optimize probiotic interventions against MP toxicity.